Etirinotecan pegol (NKTR-102) versus treatment of physician's choice in women with advanced breast cancer previously treated with an anthracycline, a taxane, and capecitabine (BEACON): a randomised, open-label, multicentre, phase 3 trial.
| Image |  |
|---|---|
| Description | scientific article published on 15 October 2015 |
| Author/s |
author: Chris Twelves Javier Cortes Hope Rugo Denise A Yardley Seock-Ah Im Ute Hoch Joyce O'Shaughnessy Lee S Schwartzberg Edith A. Perez Audrey Mailliez Alvaro Moreno-Aspitia Mary Tagliaferri Alison L Hannah Jin-Seok Ahn Patricia Gómez-Pardo |
| Publication date | October 15, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |